Recent Press Releases

TKL Research Opens Research Clinic at the Fair Lawn Promenade

FAIR LAWN, N.J.--TKL Research, a full-service clinical research organization (CRO), is proud to announce the opening of its new research clinic in Fair Lawn, NJ. TKL's largest clinic to date,...

WuXi PharmaTech Completes Construction of New Biosafety Testing Facility in Suzhou

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today...

Bayer HealthCare extends access to clinical trial data

Bayer HealthCare joins internet portal "www.clinicalstudydatarequest.com" / Access to clinical trial data for qualified researchers fosters scientific innovation and development of...

PRA Adds Large Molecule Capabilities to U.S. Laboratory

Immunochemistry Services Now Available in Kansas RALEIGH, N.C. and LENEXA, Kansas – PRA, a leading clinical research organization, today announced that in addition to offering full-service...

Evotec AG reports results of first quarter 2014

- CONTINUING TO ACCELERATE INNOVATION EFFICIENCY STRATEGY IN NEWLY SEGMENTED BUSINESS FORMATION Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today reported...

WuXi PharmaTech Announces First-Quarter 2014 Results

SHANGHAI, May 14, 2014 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving the pharmaceutical, biotechnology, and medical device industries, with...

Quintiles Announces Agreement to Acquire Encore Health Resources

Acquisition Will Bolster Quintiles' Expertise in Health-Information Analytics Services and Create Foundation for Expanded Services Suite RESEARCH TRIANGLE PARK, N.C. – May 12, 2014 –...

Evotec and Eternygen enter collaboration to identify and develop novel metabolic disease therapy

Berlin and Hamburg, Germany - Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Eternygen GmbH, a privately owned biopharmaceutical company, today announced a drug discovery...

ICON Completes Acquisition of Aptiv Solutions

DUBLIN--ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has completed the...

WuXi PharmaTech Begins Construction of New R&D and cGMP Manufacturing Campus in Changzhou

SHANGHAI, May 8, 2014 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device research and development (R&D) services company with operations in...

WuXi PharmaTech Completes Construction of New Materials Characterization Facility in St. Paul

SHANGHAI, May 12, 2014 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United...

Tigermed and Frontage Laboratories Announce Strategic Investment to Strengthen Global Drug Development Service Capabilities

EXTON, Pa.--Hangzhou Tigermed Consulting Co., Ltd. (hereafter 'Tigermed'), a leading provider of outsourced clinical development services across China and Asia Pacific to the pharmaceutical...

ONYX COMPLETES API PROJECT WITH US DRUG DEVELOPER

UK-based contract research organisation Onyx Scientific has completed a development and API manufacturing project with US-based Neuronascent, Inc to support the company with its focus on neurologic...

AMRI Announces First Quarter 2014 Results

Contract Revenue Growth of 10% to $51.0 Million and Adjusted Diluted EPS of $0.16 Company Increases 2014 Adjusted EPS Guidance to $0.78 - $0.84 to Reflect Addition of Cedarburg Pharmaceuticals and...

Cytovance Biologics, Inc. and Selexys Pharmaceuticals, Corp. Announce Development and cGMP Manufacturing Agreement for SELK2 Drug Product

Cytovance Biologics, Inc. and Selexys Pharmaceuticals, Corp. Announce Development and cGMP Manufacturing Agreement for SELK2 Drug Product Oklahoma City, OK (May 6, 2014)-- Cytovance Biologics, Inc.,...

Avillion Announces Royalty Pharma Investment

Jim Reddoch, PhD, Royalty Pharma Executive Vice President for Research and Investments Joins Avillion Board LONDON (UK) and NEW YORK, NY (US), May 6, 2014 – Avillion LLP, a company focused on...

Huntingdon Life Sciences Acquires Harlan Laboratories

HUNTINGDON, England -- Huntingdon Life Sciences announced today that it has acquired Harlan Laboratories. The new company will have two operating divisions: Research Models and Services and Contract...

TrialNetworks Joins the DrugDev Family of Technology-Driven Solutions to Advance the Common Goal of Enabling More Efficient Clinical Trials

Audubon, PA and Newton, Mass. - May 5, 2014 - DrugDev, the industry's largest global network of active clinical trial doctors, today announced its acquisition of TrialNetworks. The award-winning...

WuXi PharmaTech Facilities for Late - and Commercial-Stage Analytical and Stability Testing and Clinical-Trial Materials Manufacturing Pass FDA Audit

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today...

COVANCE LAUNCHES NEW BRAND: SOLUTIONS MADE REAL™

PRINCETON, N.J. -- Covance Inc. (NYSE: CVD), the world's most comprehensive drug development company, today announced its new brand, Solutions Made RealTM. This brand strategy more effectively...